AzTrials
AzTrials

Eating DisordersSPETCANCT04864626

Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral Center

An observational study of Eating Disorders and Recurrence, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The referral center for eating disorders provides for a systematic many years follow-up of patients under care with an annual assessment at the center. The investigators have recently shown the frequency of relapse in the first 7 years after diagnosis, but the literature remains poor on this epidemiology and on the… Read more about this study

Who is it for?
Ages 3 years and older
Conditions the study is for
Eating Disorders, Recurrence, Relapse
What is being tested?
semi-standardized interview and care experience questionary
How many people
250 participants
Where
1 siteFrance
Study dates
16 Jun 2021to 1 Jan 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: patient with eating disorders

Who may be able to join

  • Patients diagnosed with an eating disorder confirmed at the multidisciplinary consultation meeting of the referring center and considered cured (in remission). For patients with Oral Disorders, inclusion is within one year of recovery
  • Patient affiliated or entitled to a social security plan
  • Oral participation agreement
  • Pregnant women

Who cannot join

  • Persons deprived of liberty
  • Patients under guardianship or curatorship
  • refusal to participate

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de SAINT-ETIENNE

    Saint-Etienne, 42000

Other trials in France

About this study

The referral center for eating disorders provides for a systematic many years follow-up of patients under care with an annual assessment at the center. The investigators have recently shown the frequency of relapse in the first 7 years after diagnosis, but the literature remains poor on this epidemiology and on the risk factors for relapse. The investigators would therefore like to extend this follow-up for an additional 3 years after remission with an annual telephone nursing interview for all cured patients.

Being tested
semi-standardized interview, care experience questionary
Medical subject headings
Feeding and Eating Disorders, Recurrence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • semi-standardized interviewOther

    annual collection of the number of consultations and hospitalizations at the center, as well as the number of treatments

  • care experience questionaryOther

    questionary with 12 questions to rate the quality of the telephone reception and your feelings during the interview

Study groups in NCT04864626
Study groupRoleWhat they receive
patient with eating disorderNot described
Receives: Other: semi-standardized interview; Other: care experience questionary

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of relapses/recurrences per year

    Measured: 3 years

Secondary outcomes (9)
  1. risk factors for relapse/recurrence

    To determinate if one or more factors below could be a risk factors for relapse/recurrence :

    • Age
    • Sex
    • Body mass index
    • Contraception use
    • History of an eating disorder
    • Intense physical activity
    • History of psychiatric hospitalization
    • History of suicide attempt
    • Presence of psychotropic treatment of any kind

    Measured: 3 years

  2. Number of patients called per year

    Measured: 3 years

  3. Number of calls made per patient per year

    Measured: 3 years

  4. Number of completed calls per patient per year

    Measured: 3 years

  5. Number of telephone sessions per year per patient

    Measured: 3 years

  6. Duration of telephone sessions

    Measured: 3 years

  7. Number of lost to follow-up per year

    Measured: 3 years

  8. Number of patients not cured

    Measured: 3 years

  9. Analysis of the experience of care questionnaire

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2021
  2. Study start16 Jun 2021
  3. Primary completion13 Sep 2024
  4. Study completion1 Jan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
250 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04864626
Sponsor's protocol ID
19PH227
Other IDs
2020-A02830-39
Acronym
SPETCA
Status last verified
May 2026
First submitted
26 Apr 2021
Last updated
6 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Eating Disorders and Recurrence, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 6 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of relapses/recurrences per year (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in